Kevin McCulloch

See Remarks

Kevin McCulloch (See Remarks) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Xeris Biopharma Holdings, Inc. (XERS). The largest single filing was $723K of XERS (90,000 sh × $8.03, as filed), executed Jul 1.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.1M

shares × price, as filed

Last traded

Sep 1

Filed Sep 1

Median ADV $16.5M across their filed names

Open performance→

Volume by month

Buys $110K Sells $1.1M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

XERS Xeris Biopharma Holdings, Inc. XERS · 1 buy · 4 sells 5 filings

Recent filings

XERSSALE Xeris Biopharma Holdings, Inc. View filing → $127K
15,000 sh × $8.49
Exec Sep 1
Filed Sep 1 · 6:21 PM ET XERSSALE Xeris Biopharma Holdings, Inc. View filing → $120K
15,000 sh × $8.02
Exec Aug 3
Filed Aug 4 · 5:30 PM ET XERSSALE Xeris Biopharma Holdings, Inc. View filing → $723K
90,000 sh × $8.03
Exec Jul 1
Filed Jul 2 · 4:40 PM ET XERSSALE Xeris Biopharma Holdings, Inc. View filing → $120K
15,000 sh × $8.00
Exec Jan 8
Filed Jan 9 · 5:30 PM ET XERSPURCHASE Xeris Biopharma Holdings, Inc. View filing → $110K
25,000 sh × $4.38
Exec Jun 13 2025
Filed Jun 16 2025 · 5:30 PM ET